PTN22_HUMAN - dbPTM
PTN22_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PTN22_HUMAN
UniProt AC Q9Y2R2
Protein Name Tyrosine-protein phosphatase non-receptor type 22
Gene Name PTPN22
Organism Homo sapiens (Human).
Sequence Length 807
Subcellular Localization Cytoplasm.
Protein Description Acts as negative regulator of T-cell receptor (TCR) signaling by direct dephosphorylation of the Src family kinases LCK and FYN, ITAMs of the TCRz/CD3 complex, as well as ZAP70, VAV, VCP and other key signaling molecules. [PubMed: 16461343]
Protein Sequence MDQREILQKFLDEAQSKKITKEEFANEFLKLKRQSTKYKADKTYPTTVAEKPKNIKKNRYKDILPYDYSRVELSLITSDEDSSYINANFIKGVYGPKAYIATQGPLSTTLLDFWRMIWEYSVLIIVMACMEYEMGKKKCERYWAEPGEMQLEFGPFSVSCEAEKRKSDYIIRTLKVKFNSETRTIYQFHYKNWPDHDVPSSIDPILELIWDVRCYQEDDSVPICIHCSAGCGRTGVICAIDYTWMLLKDGIIPENFSVFSLIREMRTQRPSLVQTQEQYELVYNAVLELFKRQMDVIRDKHSGTESQAKHCIPEKNHTLQADSYSPNLPKSTTKAAKMMNQQRTKMEIKESSSFDFRTSEISAKEELVLHPAKSSTSFDFLELNYSFDKNADTTMKWQTKAFPIVGEPLQKHQSLDLGSLLFEGCSNSKPVNAAGRYFNSKVPITRTKSTPFELIQQRETKEVDSKENFSYLESQPHDSCFVEMQAQKVMHVSSAELNYSLPYDSKHQIRNASNVKHHDSSALGVYSYIPLVENPYFSSWPPSGTSSKMSLDLPEKQDGTVFPSSLLPTSSTSLFSYYNSHDSLSLNSPTNISSLLNQESAVLATAPRIDDEIPPPLPVRTPESFIVVEEAGEFSPNVPKSLSSAVKVKIGTSLEWGGTSEPKKFDDSVILRPSKSVKLRSPKSELHQDRSSPPPPLPERTLESFFLADEDCMQAQSIETYSTSYPDTMENSTSSKQTLKTPGKSFTRSKSLKILRNMKKSICNSCPPNKPAESVQSNNSSSFLNFGFANRFSKPKGPRNPPPTWNI
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
9UbiquitinationDQREILQKFLDEAQS
CHHHHHHHHHHHHHH
44.44-
17UbiquitinationFLDEAQSKKITKEEF
HHHHHHHCCCCHHHH
35.79-
17UbiquitinationFLDEAQSKKITKEEF
HHHHHHHCCCCHHHH
35.79-
18UbiquitinationLDEAQSKKITKEEFA
HHHHHHCCCCHHHHH
61.94-
18UbiquitinationLDEAQSKKITKEEFA
HHHHHHCCCCHHHHH
61.94-
21UbiquitinationAQSKKITKEEFANEF
HHHCCCCHHHHHHHH
59.73-
21UbiquitinationAQSKKITKEEFANEF
HHHCCCCHHHHHHHH
59.73-
30UbiquitinationEFANEFLKLKRQSTK
HHHHHHHHHHHCCCC
58.23-
32UbiquitinationANEFLKLKRQSTKYK
HHHHHHHHHCCCCCC
46.97-
32UbiquitinationANEFLKLKRQSTKYK
HHHHHHHHHCCCCCC
46.97-
35PhosphorylationFLKLKRQSTKYKADK
HHHHHHCCCCCCCCC
30.7918056643
43PhosphorylationTKYKADKTYPTTVAE
CCCCCCCCCCCCHHC
34.9730242111
44PhosphorylationKYKADKTYPTTVAEK
CCCCCCCCCCCHHCC
12.3430242111
46PhosphorylationKADKTYPTTVAEKPK
CCCCCCCCCHHCCCC
24.4030242111
47PhosphorylationADKTYPTTVAEKPKN
CCCCCCCCHHCCCCC
17.1430242111
51UbiquitinationYPTTVAEKPKNIKKN
CCCCHHCCCCCCCCC
52.10-
61UbiquitinationNIKKNRYKDILPYDY
CCCCCCCCCCCCCCC
34.75-
61UbiquitinationNIKKNRYKDILPYDY
CCCCCCCCCCCCCCC
34.75-
84PhosphorylationTSDEDSSYINANFIK
ECCCCCCCCCCCEEC
11.35-
142PhosphorylationGKKKCERYWAEPGEM
CHHHHHHHCCCCCEE
6.1529116813
166UbiquitinationSCEAEKRKSDYIIRT
EEEEHHHCCCEEEEE
59.76-
166UbiquitinationSCEAEKRKSDYIIRT
EEEEHHHCCCEEEEE
59.76-
167PhosphorylationCEAEKRKSDYIIRTL
EEEHHHCCCEEEEEE
39.4123532336
169PhosphorylationAEKRKSDYIIRTLKV
EHHHCCCEEEEEEEE
12.8229457462
173PhosphorylationKSDYIIRTLKVKFNS
CCCEEEEEEEEEECC
22.11-
260UbiquitinationPENFSVFSLIREMRT
CCCCCHHHHHHHHHH
22.26-
300UbiquitinationQMDVIRDKHSGTESQ
HHHHHHCCCCCCHHH
29.80-
309UbiquitinationSGTESQAKHCIPEKN
CCCHHHHHHCCCCCC
31.22-
309UbiquitinationSGTESQAKHCIPEKN
CCCHHHHHHCCCCCC
31.22-
315UbiquitinationAKHCIPEKNHTLQAD
HHHCCCCCCCEECCC
48.99-
318PhosphorylationCIPEKNHTLQADSYS
CCCCCCCEECCCCCC
29.9327080861
323PhosphorylationNHTLQADSYSPNLPK
CCEECCCCCCCCCCH
30.4423401153
324PhosphorylationHTLQADSYSPNLPKS
CEECCCCCCCCCCHH
28.7928450419
325PhosphorylationTLQADSYSPNLPKST
EECCCCCCCCCCHHH
15.9723401153
330UbiquitinationSYSPNLPKSTTKAAK
CCCCCCCHHHHHHHH
64.70-
337AcetylationKSTTKAAKMMNQQRT
HHHHHHHHHHHHHHH
43.4725953088
337UbiquitinationKSTTKAAKMMNQQRT
HHHHHHHHHHHHHHH
43.47-
341UbiquitinationKAAKMMNQQRTKMEI
HHHHHHHHHHHCHHH
19.08-
345UbiquitinationMMNQQRTKMEIKESS
HHHHHHHCHHHHHCC
36.40-
351PhosphorylationTKMEIKESSSFDFRT
HCHHHHHCCCCCCCC
26.7027251275
352PhosphorylationKMEIKESSSFDFRTS
CHHHHHCCCCCCCCC
35.8027251275
353PhosphorylationMEIKESSSFDFRTSE
HHHHHCCCCCCCCCC
37.8127251275
356UbiquitinationKESSSFDFRTSEISA
HHCCCCCCCCCCCCC
9.64-
364AcetylationRTSEISAKEELVLHP
CCCCCCCCEEEEECC
44.9519822837
364UbiquitinationRTSEISAKEELVLHP
CCCCCCCCEEEEECC
44.95-
373AcetylationELVLHPAKSSTSFDF
EEEECCCCCCCCCEE
49.7619822847
374UbiquitinationLVLHPAKSSTSFDFL
EEECCCCCCCCCEEE
40.74-
374PhosphorylationLVLHPAKSSTSFDFL
EEECCCCCCCCCEEE
40.7426074081
375PhosphorylationVLHPAKSSTSFDFLE
EECCCCCCCCCEEEE
27.6226074081
376PhosphorylationLHPAKSSTSFDFLEL
ECCCCCCCCCEEEEE
40.2726074081
377PhosphorylationHPAKSSTSFDFLELN
CCCCCCCCCEEEEEE
25.4326074081
386UbiquitinationDFLELNYSFDKNADT
EEEEEEEEECCCCCC
26.37-
393UbiquitinationSFDKNADTTMKWQTK
EECCCCCCCCEEECC
26.78-
396UbiquitinationKNADTTMKWQTKAFP
CCCCCCCEEECCCCC
33.77-
400UbiquitinationTTMKWQTKAFPIVGE
CCCEEECCCCCCCCC
32.69-
406UbiquitinationTKAFPIVGEPLQKHQ
CCCCCCCCCCCHHCC
31.37-
411UbiquitinationIVGEPLQKHQSLDLG
CCCCCCHHCCCCCHH
51.82-
411UbiquitinationIVGEPLQKHQSLDLG
CCCCCCHHCCCCCHH
51.82-
414PhosphorylationEPLQKHQSLDLGSLL
CCCHHCCCCCHHHHH
24.4620058876
419PhosphorylationHQSLDLGSLLFEGCS
CCCCCHHHHHHCCCC
29.2428450419
429UbiquitinationFEGCSNSKPVNAAGR
HCCCCCCCCCCCHHH
58.18-
441UbiquitinationAGRYFNSKVPITRTK
HHHHCCCCCCCCCCC
53.81-
447PhosphorylationSKVPITRTKSTPFEL
CCCCCCCCCCCHHHH
22.2423401153
448UbiquitinationKVPITRTKSTPFELI
CCCCCCCCCCHHHHH
49.38-
449PhosphorylationVPITRTKSTPFELIQ
CCCCCCCCCHHHHHH
40.4723401153
450PhosphorylationPITRTKSTPFELIQQ
CCCCCCCCHHHHHHC
33.2928122231
451UbiquitinationITRTKSTPFELIQQR
CCCCCCCHHHHHHCC
28.01-
461UbiquitinationLIQQRETKEVDSKEN
HHHCCCCCCCCCHHC
51.49-
466UbiquitinationETKEVDSKENFSYLE
CCCCCCCHHCCHHHH
52.81-
493PhosphorylationAQKVMHVSSAELNYS
CCEEEEECHHHCCCC
14.7826434552
494PhosphorylationQKVMHVSSAELNYSL
CEEEEECHHHCCCCC
25.3626434552
499PhosphorylationVSSAELNYSLPYDSK
ECHHHCCCCCCCCCH
24.9828796482
500PhosphorylationSSAELNYSLPYDSKH
CHHHCCCCCCCCCHH
23.0728796482
503PhosphorylationELNYSLPYDSKHQIR
HCCCCCCCCCHHHHC
37.8427080861
505PhosphorylationNYSLPYDSKHQIRNA
CCCCCCCCHHHHCCC
26.6227080861
506UbiquitinationYSLPYDSKHQIRNAS
CCCCCCCHHHHCCCH
36.31-
526PhosphorylationDSSALGVYSYIPLVE
CCCCCCEEEECCCCC
8.24-
527PhosphorylationSSALGVYSYIPLVEN
CCCCCEEEECCCCCC
17.74-
528PhosphorylationSALGVYSYIPLVENP
CCCCEEEECCCCCCC
6.72-
536PhosphorylationIPLVENPYFSSWPPS
CCCCCCCCCCCCCCC
27.89-
550PhosphorylationSGTSSKMSLDLPEKQ
CCCCCCEECCCCCCC
23.5928348404
585UbiquitinationYNSHDSLSLNSPTNI
CCCCCCCCCCCCCCH
29.47-
592UbiquitinationSLNSPTNISSLLNQE
CCCCCCCHHHHHCHH
3.05-
594UbiquitinationNSPTNISSLLNQESA
CCCCCHHHHHCHHCH
32.83-
609UbiquitinationVLATAPRIDDEIPPP
HHHCCCCCCCCCCCC
8.35-
635PhosphorylationVEEAGEFSPNVPKSL
EEECCCCCCCCCCCH
15.9728348404
640UbiquitinationEFSPNVPKSLSSAVK
CCCCCCCCCHHCCEE
60.80-
647UbiquitinationKSLSSAVKVKIGTSL
CCHHCCEEEEECCCC
37.21-
649UbiquitinationLSSAVKVKIGTSLEW
HHCCEEEEECCCCCC
29.69-
653PhosphorylationVKVKIGTSLEWGGTS
EEEEECCCCCCCCCC
21.05-
663UbiquitinationWGGTSEPKKFDDSVI
CCCCCCCCCCCCCEE
63.12-
664UbiquitinationGGTSEPKKFDDSVIL
CCCCCCCCCCCCEEE
65.82-
675UbiquitinationSVILRPSKSVKLRSP
CEEECCCCCEECCCC
63.05-
684PhosphorylationVKLRSPKSELHQDRS
EECCCCCHHHCCCCC
49.1028464451
691PhosphorylationSELHQDRSSPPPPLP
HHHCCCCCCCCCCCC
56.3323401153
692PhosphorylationELHQDRSSPPPPLPE
HHCCCCCCCCCCCCH
42.1723911959
715UbiquitinationADEDCMQAQSIETYS
CCHHHHHCCCCEEEC
4.35-
741PhosphorylationSSKQTLKTPGKSFTR
CCCCCCCCCCCCCCH
40.1523532336
744UbiquitinationQTLKTPGKSFTRSKS
CCCCCCCCCCCHHHH
43.53-
745PhosphorylationTLKTPGKSFTRSKSL
CCCCCCCCCCHHHHH
37.4530622161
747PhosphorylationKTPGKSFTRSKSLKI
CCCCCCCCHHHHHHH
40.9230622161
749PhosphorylationPGKSFTRSKSLKILR
CCCCCCHHHHHHHHH
24.4430622161
751PhosphorylationKSFTRSKSLKILRNM
CCCCHHHHHHHHHHC
35.8230622161
770UbiquitinationCNSCPPNKPAESVQS
HHCCCCCCCCHHHCC
51.91-
793PhosphorylationFGFANRFSKPKGPRN
CCCCCCCCCCCCCCC
44.8224719451

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
35SPhosphorylationKinasePKCDQ05655
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
35SPhosphorylation

18056643

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PTN22_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
GRB2_HUMANGRB2physical
11882361
SPTA1_HUMANSPTA1physical
16461343
TERA_HUMANVCPphysical
16461343
VAV_HUMANVAV1physical
16461343
ZAP70_HUMANZAP70physical
16461343
LCK_HUMANLCKphysical
16461343
ACTS_HUMANACTA1physical
16461343
CD3E_HUMANCD3Ephysical
16461343
CD3Z_HUMANCD247physical
16461343
PTN22_HUMANPTPN22physical
10068674
CBL_HUMANCBLphysical
10068674
PPIP2_HUMANPSTPIP2physical
27880917
TBC31_HUMANTBC1D31physical
27880917
KIF7_HUMANKIF7physical
27880917
CSK_HUMANCSKphysical
27880917
LZTS2_HUMANLZTS2physical
27880917
CP131_HUMANCEP131physical
27880917
PIBF1_HUMANPIBF1physical
27880917
MOONR_HUMANKIAA0753physical
27880917
MIB1_HUMANMIB1physical
27880917
MED4_HUMANMED4physical
27880917
ADIP_HUMANSSX2IPphysical
27880917
CC138_HUMANCCDC138physical
27880917
PTN22_HUMANPTPN22physical
27432908
PPIP2_HUMANPSTPIP2physical
27432908
CSK_HUMANCSKphysical
27432908
MD2BP_HUMANMAD2L1BPphysical
27432908
NDUBA_HUMANNDUFB10physical
27432908
KAP2_HUMANPRKAR2Aphysical
27432908
ARK72_HUMANAKR7A2physical
27432908
NDUA9_HUMANNDUFA9physical
27432908
CALR_HUMANCALRphysical
27432908
CALU_HUMANCALUphysical
27432908
TPC_HUMANSLC25A19physical
27432908
CAB45_HUMANSDF4physical
27432908
MAIP1_HUMANC2orf47physical
27432908
AROS_HUMANRPS19BP1physical
27432908
SFXN4_HUMANSFXN4physical
27432908
EIF3E_HUMANEIF3Ephysical
27432908
HSPB1_HUMANHSPB1physical
27432908
RCN1_HUMANRCN1physical
27432908
ACAD8_HUMANACAD8physical
27432908
DHE3_HUMANGLUD1physical
27432908
HAX1_HUMANHAX1physical
27432908
SCO2_HUMANSCO2physical
27432908

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
152700Systemic lupus erythematosus (SLE)
222100Diabetes mellitus, insulin-dependent (IDDM)
180300Rheumatoid arthritis (RA)
193200Vitiligo (VTLG)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PTN22_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.";
Yu X., Sun J.P., He Y., Guo X., Liu S., Zhou B., Hudmon A.,Zhang Z.Y.;
Proc. Natl. Acad. Sci. U.S.A. 104:19767-19772(2007).
Cited for: X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-294 IN COMPLEX WITHINHIBITOR, FUNCTION, PHOSPHORYLATION AT SER-35, AND MUTAGENESIS OFSER-35 AND THR-36.

TOP